[Chemotherapy-induced peripheral neuropathy: Symptomatology and epidemiology]

Bull Cancer. 2018 Nov;105(11):1020-1032. doi: 10.1016/j.bulcan.2018.07.009. Epub 2018 Sep 20.
[Article in French]

Abstract

Chemotherapy-induced peripheral neuropathy (CIPN) is common with specific semiological characteristics. When CIPN appears, there are many difficulties in guaranteeing sustained treatment, especially with optimal protocol. Moreover, CIPN have bad repercussions on quality of life after cancer disease. In this article, we have achieved a current state of CIPN and try to report details about semiological characteristics and topography. We have also produced some epidemiological data. Nonetheless, we have not voluntarily introduced treatment because it will be the topic of further work.

Keywords: Chemotherapy; Chimiothérapie; Douleur; Neuropathie périphérique; Pain; Peripheral neuropathy; Quality of life; Qualité de vie.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Bortezomib / adverse effects
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Neoplasms / drug therapy*
  • Peripheral Nervous System Diseases / chemically induced*
  • Peripheral Nervous System Diseases / diagnosis
  • Peripheral Nervous System Diseases / epidemiology
  • Platinum Compounds / adverse effects
  • Quality of Life
  • Symptom Assessment
  • Taxoids / adverse effects
  • Thalidomide / adverse effects
  • Vinca Alkaloids / adverse effects

Substances

  • Antineoplastic Agents
  • Immunosuppressive Agents
  • Platinum Compounds
  • Taxoids
  • Vinca Alkaloids
  • Thalidomide
  • Bortezomib